No Detail Found!

Impact of Antenatal Corticosteroid Administration Timing on Neonatal Respiratory Outcomes in Preterm Births

Author(s)
Reem Ayed Alshammari Department of Peadriatic, College of Medicine, University of Ha’il, SaudiArabia
Abeer Hassan Elhaj Department of Family Medicine, College of Medicine, University of Ha’il, 2440, Saudi Arabia
Naglaa Ahmed Abdellatif Ginawi Department of Accademic Affairs hail Health Cluster_quality, Hail University, Saudi Arabia
Manal Zayed Alshammary Pediatric Endocrinologist, College of Medicine, University of Hail, Saudi Arabia
Fahmida Khatoon Department of Biochemistry, College of Medicine, University of Ha’il, Saudi Arabia
Einas Mustafa Mudawi Ahmed Department of Obstetrics and Gynecology, Faculty of Medicine, Najran University, Najran, Saudi Arabia
Hamdan Siddig Sirag Ahmad Department of Obstetrics and Gynecology, Faculty of Medicine, Najran University, Najran, Saudi Arabia
Nowayer Suhyeman Al Shammari College of Medicine, University of Ha’il, 2440, Saudi Arabia
Saud Obaykay Abdulkarim Alshammary College of Medicine, University of Ha’il, 2440, Saudi Arabia
Khalid Saud Mahal Alnawmasi College of Medicine, University of Ha’il, 2440, Saudi Arabia
Mohammed Musaad Abdullah Alshammari College of Medicine, University of Ha’il, 2440, Saudi Arabia
Mwahib Mohamed Ahmed Department of Anatomy, College of Medicine, University of Ha’il, 2440 Hail, Saudi Arabia
Reem Daher Alshammari Hail Health Cluster, 2440 Hail, Saudi Arabia
Abstract
Background: Respiratory complications remain a leading cause of morbidity and mortality in preterm neonates. Antenatal corticosteroids (ACS) are known to accelerate fetal lung maturation but the timing of administration in relation to delivery may significantly influence outcomes. Objective: This study aimed to evaluate the impact of ACS timing on neonatal respiratory outcomes in preterm births. Methods: A prospective observational study was conducted on 321 pregnant women who delivered between 24+0 and 34+6 weeks of gestation at [Insert Hospital Name]. Participants were categorized based on the interval between ACS administration and delivery: Group A (1-7 days), Group B (7 days). Neonatal outcomes including Respiratory Distress Syndrome (RDS), need for respiratory support, oxygen therapy duration, NICU stay and early neonatal mortality were recorded. Data were analyzed using SPSS [insert version], with p<0.05 considered statistically significant. Results: The incidence of RDS was significantly lower in Group A (27.8%) compared to Group B (51.0%) and Group C (48.7%) (p<0.001). Mechanical ventilation was required in 11.1% of Group A neonates, versus 27.1% in Group B and 21.4% in Group C (p = 0.003). CPAP need followed a similar trend (25.9, 41.7 and 42.7%, respectively; p = 0.01). The mean duration of oxygen therapy and NICU stay was also lowest in Group A (2.8±1.3 and 6.7±2.5 days, respectively; both p<0.001). Early neonatal mortality was lowest in Group A (3.7%) compared to Group B (8.3%) and Group C (7.7%), though not statistically significant (p = 0.09). Conclusion: It is concluded that administering antenatal corticosteroids within 1 to 7 days of preterm delivery is associated with significantly improved neonatal respiratory outcomes. Optimal timing reduces the risk of RDS, decreases the need for respiratory support and shortens NICU stays. These findings reinforce the need for timely intervention and coordination in obstetric care to maximize the therapeutic benefits of corticosteroids in preterm births.
Publication Details
Page(s) 148-152
Published Journal: Journal of Pioneering Medical Sciences, Volume: 14, Issue: 10, Year: 2025

Request the full text from PASTIC

Keywords
Neonatal mortality, Antenatal Corticosteroids, neonatal outcomes, Fetal Lung Maturation, Respiratory Distress Syndrome (RDS), NICU Stay
References
Liggins G.C.,Howie R.N. . .“A Controlled Trial of Antepartum Glucocorticoid Treatment for Prevention of the Respiratory Distress Syndrome in Premature Infants. ” Pediatrics, 50(1972) : 515-525.
Roberts S.,Dalziel S. .2006 .Antenatal Corticosteroids for Accelerating Fetal Lung Maturation for Women at Risk of Preterm Birth.” Cochrane Database of Systematic Reviews. , (3) : CD004454.
McGoldrick E. .2020 .Antenatal Corticosteroids for Accelerating Fetal Lung Maturation for Women at Risk of Preterm Birth.” Cochrane Database of Systematic Reviews. , 12 : CD004454.
Peaceman A.M. . .The Interval between a Single Course of Antenatal Steroids and Delivery and Its Association with Neonatal Outcomes. American Journal of Obstetrics and Gynecology, 193(2005) : 1165-1169.
Viteri O.A. . .Antenatal Corticosteroids for the Prevention of Respiratory Distress Syndrome in Premature Twins. Obstetrics & Gynecology, 128(2016) : 583-591.
Ushida T. . .. Antenatal Corticosteroids and Outcomes in Preterm Twins.” Obstetrics & Gynecology, 135(2020) : 1387-1397.
Sotiriadis A. .2021 .Antenatal Corticosteroids Prior to Planned Caesarean at Term for Improving Neonatal Outcomes. Cochrane Database of Systematic Reviews, 12 : CD006614.
Waters T.P.,Mercer B. . .. Impact of Timing of Antenatal Corticosteroid Exposure on Neonatal Outcomes.” Journal of Maternal-Fetal and Neonatal Medicine, 22(2009) : 311-314.
Gates S.,Brocklehurst P. .2007 .Decline in Effectiveness of Antenatal Corticosteroids with Time to Birth: Real or Artefact?” BMJ. , 335(7610) : 77-79.
Datkhaeva I. . .Uptake of a Guideline for the Administration of a Rescue Course of Antenatal Corticosteroids. Obstetrics & Gynecology, 129(2017) : 720-726.
Doyle L.W. . .Antenatal Corticosteroids and Outcomes into Adulthood. ” Paediatric and Perinatal Epidemiology, 36(2022) : 640-642.
Socha P. . .Antenatal Corticosteroids and Neonatal Outcomes in Twins: A Systematic Review and MetaAnalysis. Obstetrics & Gynecology, 140(2022) : 20-30.
Carlo W.A. .2011 .Association of Antenatal Corticosteroids with Mortality and Neurodevelopmental Outcomes among Infants Born at. ” JAMA, 306(21) : 2348-2358.
Gyamfi-Bannerman C. .2016 .Antenatal Betamethasone for Women at Risk for Late Preterm Delivery. ” New England Journal of Medicine, 374(14) : 1311-1320.
Carlo W.A. . .Respiratory Outcomes in Extremely Preterm Infants: Effect of Antenatal Corticosteroids. ” JAMA, 297(2007) : 112-123.
Murphy K.E. .2008 .Multiple Courses of Antenatal Corticosteroids for Preterm Birth (MACS): A Randomized Controlled Trial. ” Lancet, 372(9656) : 2143-2151.
Crowther C.A. .2006 .Neonatal Respiratory Distress Syndrome after Repeat Exposure to Antenatal Corticosteroids: A Randomized Controlled Trial. ” Lancet, 367(9526) : 1913-1919.
0

Citations

0

Downloads

37

Views